Inquiry
Form loading...
While historically recognized as a powerful antifibrinolytic agent to control bleeding, Tranexamic Acid (TXA) has witnessed a revolutionary transition into the aesthetic and dermatological sciences. In the pursuit of ageless skin, the cosmetic industry has shifted its focus from merely addressing structural wrinkles to resolving complex pigmentary changes, chronic micro-inflammation, and vascular hyper-reactivity—collectively known as "inflammaging."
As a synthetic derivative of the amino acid lysine, Tranexamic Acid (CAS 1197-18-8) targets the very pathways that lead to photoaging and age-induced hyperpigmentation. When skin is exposed to ultraviolet (UV) radiation or chronic environmental stressors, keratinocytes release plasminogen activator, which converts plasminogen into plasmin. Plasmin triggers the release of inflammatory mediators like arachidonic acid and prostaglandins. These compounds stimulate melanocytes to produce excess melanin, resulting in age spots, melasma, and uneven skin tone. By blocking this pathway, Tranexamic Acid acts as a powerful shield against photoaging.
Tranexamic Acid does not merely bleach the skin; it modulates the biological communication between keratinocytes and melanocytes. This targeted action makes it vastly superior to traditional harsh depigmenting agents. Its anti-aging properties extend beyond pigmentation control:
When formulated with Azelaic Acid, the anti-aging benefits are compounded. While Tranexamic Acid prevents pigment activation at the early inflammatory stage, Azelaic Acid selectively targets overactive melanocytes and promotes healthy cellular turnover. This dual action resolves deep-seated senile lentigines (age spots) while refining skin texture and reducing fine lines.
The global demand for high-purity cosmetic raw materials has surged, driven by consumers seeking clinical-grade, science-backed skincare. The market size for Tranexamic Acid in cosmetic applications is expanding at a significant CAGR, particularly in the Asia-Pacific and North American regions.
Industrially, the challenge lies in producing a highly stable, bioavailable, and non-irritating form of Tranexamic Acid. Shaanxi Qiyuan Kangjian Biotechnology Co., Ltd. addresses this demand by utilizing advanced crystallization and purification technologies, ensuring that our CAS 1197-18-8 Tranexamic Acid powder meets strict global pharmacopeia and cosmetic standards.
Regulatory bodies worldwide (including the EU SCCS and China's NMPA) approve the use of Tranexamic Acid in cosmetics, typically in concentrations ranging from 1.5% to 3% for leave-on products. This regulatory safety profile, combined with its high stability against heat and light (unlike Vitamin C or Retinol), makes it a preferred choice for R&D formulation scientists globally.
Designed for daytime application, these formulations combine Tranexamic Acid with broad-spectrum UV filters. By pre-emptively blocking the plasminogen pathway during sun exposure, it prevents the immediate triggering of melanogenesis, mitigating the cumulative solar damage that accelerates aging.
Following laser resurfacing, chemical peels, or microneedling, the skin undergoes acute inflammation, which can lead to Post-Inflammatory Hyperpigmentation (PIH). Incorporating Tranexamic Acid into post-procedure recovery creams calms erythema, accelerates tissue repair, and prevents PIH.
At night, the skin's natural repair mechanisms are highly active. Formulating Tranexamic Acid with Retinol or bio-peptides enhances cellular turnover and collagen synthesis. While peptides rebuild the extracellular matrix, TXA resolves deep-seated age spots, resulting in a refreshed, even complexion by morning.
For stubborn, localized areas of hyperpigmentation on the hands, face, and décolleté, high-concentration spot treatments combine Tranexamic Acid with Azelaic Acid. This synergy breaks down existing pigment clusters and stops the localized micro-inflammation that maintains the spot.
Shaanxi Qiyuan Kangjian Biotechnology Co., Ltd. is located in Xi'an, Shaanxi Province, China, and specializes in supplying peptides, food additives, nutritional supplements, traditional Chinese medicine (TCM) extracts, plant extracts, and natural active ingredients.
Since our establishment in 2022, we have committed ourselves to bridging the gap between nature and scientific innovation. By utilizing advanced biotechnology, we supply premium-grade active raw materials to the cosmetics, pharmaceutical, and health supplement industries globally. Our focus on quality control and compliance ensures that our partners receive ingredients that meet the highest international standards.
The company has two major production bases in Weinan and Xianyang. Weinan Shenhekang Bioengineering Co., Ltd., established in 2022, boasts a 6,000-square-meter GMP-compliant production workshop. This base is equipped with multi-functional plant extraction equipment for extraction, separation, concentration, and drying, as well as a complete production line, with an annual processing capacity of nearly 3,000 tons of various traditional Chinese medicinal materials and the production of 300 tons of raw materials.
The company has an independent R&D team and a standardized laboratory equipped with advanced testing instruments, including thin-layer chromatography (TLC), high-performance liquid chromatography (HPLC), ultraviolet-visible spectrophotometer (UV), and gas chromatography (GC), implementing strict technical control over the entire production process from raw material collection to finished product delivery.
The company has also established in-depth strategic partnerships with internationally renowned third-party testing organizations such as SGS, Eurofins, Layan Testing, and Pony Testing to ensure rigorous product quality management.
Adhering to the corporate philosophy of "rooted in our initial vision, empowered by biotechnology; upholding integrity and taking steady action to benefit the people" and the belief that "quality is our lifeline," the company leverages its group operating model and global distribution network to serve clients in the pharmaceutical, health product, and cosmetics industries.
Our products have gained global recognition and are exported to over 36 countries in Asia, the Middle East, Europe, North America, Latin America, and Africa. With independent import and export licenses, the company has established strong partnerships with international express companies and air and sea freight forwarders to provide timely and professional services. The company also offers a comprehensive sales and service system, including OEM customization services and tailored solutions for clients with new product ideas but lacking laboratory equipment and human resources.
